High-dose interferon results in high HBsAg seroclearance in children with chronic hepatitis B infection
Clinical trials for chronic hepatitis B (HBV) infection in children have shown usefulness of interferon alpha 2b (IFN-alpha) in eliminating HBV replication and in improving liver histology. Although it is not the ultimate goal of the interferon treatment for chronic HBV infection, it has been...
Saved in:
| Main Authors: | Deniz Ertem, Yeşim Acar, Esin Kotiloğlu Karaa, Ender Pehlivanoğlu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Hacettepe University Institute of Child Health
2003-04-01
|
| Series: | The Turkish Journal of Pediatrics |
| Online Access: | https://turkjpediatr.org/article/view/2872 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Prediction of long-term HBsAg seroclearance in patients with HBeAg-negative chronic hepatitis B
by: Hae Lim Lee, et al.
Published: (2025-07-01) -
Predictors of HBsAg seroclearance in HBeAg-negative chronic hepatitis B patients treated with nucleotide analogs plus polyethylene glycol interferon
by: Yan Peng, et al.
Published: (2025-01-01) -
Mechanisms underlying delayed loss of HBeAg and HBV DNA following HBsAg seroclearance in PEG-IFNα treated patients of chronic hepatitis B
by: Bei Jiang, et al.
Published: (2025-12-01) -
Concurrent presence of HBsAg and anti-HBs in children
by: H Ozen, et al.
Published: (2000-07-01) -
HBsAg and anti-HBs coexistence in patients with HBV in acute and chronic phases
by: Zhongshu Pu, et al.
Published: (2025-05-01)